Owen McManus

Owen McManus is an experienced drug discovery scientist who currently serves as the Chief Technology Officer at Q-State Biosciences, a position he has held since June 2015.23 With over three decades of experience in the biosciences field, McManus has specialized in ion channel drug discovery and has contributed to the advancement of several clinical candidates.1

Education and Early Career

McManus earned his Bachelor of Arts degree in Biology from Denison University between 1970 and 1975.2 He then pursued his PhD in Physiology at the University of Utah, graduating in 1983.2 Following his doctoral studies, McManus completed his postdoctoral work in ion channel biophysics at the University of Miami from 1983 to 1988.13

Professional Experience

Throughout his career, McManus has held several notable positions:

1. Merck Research Labs: He worked as a Senior Investigator for 21 years, from 1988 to 2009.23
2. Johns Hopkins School of Medicine: Served as the Director of Operations at the Johns Hopkins Ion Channel Center from 2010 to 2013.23
3. Essen BioScience: Held the position of Director of Ion Channel Drug Discovery and Screening from 2013 to 2015.23
4. Q-State Biosciences: Currently serving as the Chief Technology Officer since June 2015.23

Role at Q-State Biosciences

As the Chief Technology Officer at Q-State Biosciences, McManus provides guidance for drug discovery and platform development efforts.1 His extensive experience in ion channel targets and drug discovery has been instrumental in his current role, where he contributes to the company's mission of creating transformational medicines for the brain using advanced technologies.4

McManus's expertise aligns well with Q-State Biosciences' focus on integrating advanced human biology, determinative measurement engineering, and algorithmic analysis to redefine CNS drug discovery.4